Zobrazeno 1 - 10
of 100
pro vyhledávání: '"E, Doganavsargil"'
Autor:
M. Tunçyürek, Çalışkan C, Keser G, Gulsen Kandiloglu, Zütemiz Ö, Aksu K, E Doganavsargil, Doğanavşargil B
Publikováno v:
Ege Tıp Dergisi. 53:154-157
Behcet Hastaligi'nin intestinal tutulumu, Japonya ve Kore'de olgularin %50-60'inda gorulmekle birlikte Turkiye'deki sikligi %1,4'tur. Hastaligin onemli bir komplikasyonu olan intestinal perforasyonun sikligi ise bilinmemektedir. Burada hemoroid opera
Autor:
E Doganavsargil, Gökhan Keser, Murat Tombuloglu, Ayhan Donmez, Kenan Aksu, Hikmet H. Aydin, Seckin Cagirgan
Publikováno v:
Thrombosis Research. 126:207-210
To investigate the plasma levels of activated thrombin activatable fibrinolysis inhibitor (aTAFI) and thrombomodulin (TM) in Behçet disease (BD) and their relationship with thrombosis.Plasma aTAFI and TM levels were measured by ELISA in 89 patients
Autor:
Eftal Yucel, Karaarslan Y, Güher Saruhan-Direskeneli, Izzet Fresko, M. Bicakcigil, Nurullah Akkoc, Kenan Aksu, F.A. Uyar, Haner Direskeneli, Murat Inanc, Sevil Kamali, Ercan Tunc, Huseyin T. E. Ozer, Sedat Kiraz, Vuslat Yilmaz, E Doganavsargil
Publikováno v:
Human Immunology. 67:735-740
PubMedID: 17002904 Takayasu's arteritis (TA) is a chronic arterial inflammation of unknown etiology involving mainly the aorta and its major branches. Genetic polymorphisms of cytokines are screened as susceptibility factors for TA in Turkey. A total
Autor:
Kenan Aksu, E Doganavsargil, Gökhan Keser, Hakan Kültürsay, Nevbahar Turgan, Meral Kayıkçıoğlu, Can Hasdemir
Publikováno v:
Rheumatology International. 26:304-308
Behçet's disease (BD) is a systemic vasculitis, capable of involving all types of vessels. Endothelial dysfunction (ED) has been previously documented in BD. The aim of the study was to see whether ED was more prominent in Behçet's patients with va
Autor:
Gökhan Keser, Kenan Aksu, Ayhan Donmez, E Doganavsargil, Murat Tombuloglu, Handan Ak Celik, Seckin Cagirgan, Serdar Bedii Omay, Hikmet Hakan Aydin, Vedat Inal
Publikováno v:
Thrombosis Research. 115:287-292
Thrombin activatable fibrinolysis inhibitor (TAFI) is a procarboxypeptidase downregulating plasmin formation, thereby causing a tendency for thrombosis development. Since, Behçet's disease (BD) is a systemic vasculitis, which is commonly complicated
Publikováno v:
Journal of Clinical Laboratory Analysis. 19:172-176
Increased activity of urinary N‐acetyl‐β‐d‐glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as t
Autor:
Gökhan Keser, Nihal Erdem, A. Gökhan Özgen, E Doganavsargil, Kenan Aksu, Taylan Kabalak, Gürbu¨z Gümüsdis
Publikováno v:
Clinical Rheumatology. 20:44-48
It has been well established that, anti-thyroglobulin antibodies (ATG) and anti-microsomal antibodies (AMC) may be present in various thyroid disorders and other systemic autoimmune diseases, including Sjo¨gren’s syndrome (SS). However, presence o
Publikováno v:
Clinical Rheumatology. 26:173-175
There are few reports about the coexistence of Sjögren's syndrome (SS) and ankylosing spondylitis (AS). To evaluate the frequency of SS in patients with AS. We studied 70 patients with AS presenting to the university outpatient clinic between Januar
Autor:
K, Aksu, G, Kitapcioglu, G, Keser, A, Berdeli, G, Karabulut, S, Kobak, M, Ozmen, V, Inal, Y, Kabasakal, F, Oksel, H, Kocanaogullari, E, Doganavsargil
Publikováno v:
Clinical and experimental rheumatology. 26(4 Suppl 50)
Behçet's disease (BD) is a unique systemic vasculitis involving both arteries and veins of all sizes. Since Fcgamma receptors (FcgammaR) are important in mediating various immune effector functions, FcgammaR gene polymorphisms may affect the suscept
Autor:
Emin Karaca, Buket Kosova, Filiz Vural, Kenan Aksu, Ozgur Cogulu, Gökhan Keser, E Doganavsargil, Gonca Oder, Murat Tombuloglu, Cumhur Gündüz, Figen Tarhan
Publikováno v:
Rheumatology international. 28(6)
Telomerase is a reverse transcriptase enzyme contributing to the maintenance of the telomeric structure by adding telomere repeat sequences to chromosomal ends, thus compensating for its shortening. Telomerase activity which is common in cancers and